中文 | ENGLISH

Jun Wu, Ph.D.

Chairman and Managing Partner

Jun has over 20 years of experience combining venture capital investment, successful entrepreneurship, management of private and public companies and cutting-edge biomedical research. Prior to Cenova, Jun co-founded and brought public Shanghai Genomics, a multi-million dollar drug development company listed at the Tokyo Stock Exchange (GNI, 2160). During his tenure at Shanghai Genomics, Jun developed block-buster drugs. Jun has also made groundbreaking contributions to the field of immuno-oncology and has published over 30 research papers in leading scientific journals including Science, Nature, Nature Genetics, and PNAS.

Jun received his Ph.D. from the University of California at San Francisco and his postdoctoral training focusing on immuno-oncology from Merck Biologics Research Institute.